Literature DB >> 16216910

A luciferase transgenic mouse model: visualization of prostate development and its androgen responsiveness in live animals.

C-L Hsieh1, Z Xie, Z-Y Liu, J E Green, W D Martin, M W Datta, F Yeung, D Pan, L W K Chung.   

Abstract

Numerous mouse models of prostate carcinogenesis have been developed, but hitherto there has been no model in which the prostate gland could be imaged in live animals. The transgenic model generated here targeted mouse prostate gland using a firefly luciferase enzyme under the control of a small but highly active and specific supra prostate-specific antigen (sPSA) promoter. We evaluated postnatal prostate development, involution and androgen-induced restoration of prostate growth in adult transgenic mice using bioluminescence imaging. Results of our study showed that: (i) the prostate gland of male offspring did not yield a significant bioluminescence signal until after sexual maturity. Luciferase was detected in the luminal epithelial cells of the ventral and dorsolateral lobes of the prostate gland and caput epididymis, with little or no activity in 18 other organs evaluated. (ii) While a constant high level of bioluminescence was detected in the mouse prostate from 5 to 35 weeks of age, a slight drop in bioluminescence was detected at 36 to 54 weeks. (iii) Upon castration, the luciferase activity signal associated with mouse prostate detected by a cooled charge-coupled device camera was dramatically reduced. This signal could be rapidly restored to pre-castration levels after androgen administration. Androgen-induced luciferase activity subsided to nearly basal levels 5 days following the last injection. These data demonstrate that a bioluminescent mouse model with luciferase activity restricted to the prostate gland under the control of a (sPSA) promoter can be used on a real-time basis in live animals to investigate the development and responsiveness of the prostate gland to exogenously administered androgen. This model can be extended to detect the responsiveness of the prostate gland to therapy and used as a founder strain to visualize tumors in hosts with different genetic backgrounds.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16216910     DOI: 10.1677/jme.1.01722

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  13 in total

1.  Noninvasive bioluminescence imaging in small animals.

Authors:  Kurt R Zinn; Tandra R Chaudhuri; April Adams Szafran; Darrell O'Quinn; Casey Weaver; Kari Dugger; Dale Lamar; Robert A Kesterson; Xiangdong Wang; Stuart J Frank
Journal:  ILAR J       Date:  2008

2.  All-optical anatomical co-registration for molecular imaging of small animals using dynamic contrast.

Authors:  Elizabeth M C Hillman; Anna Moore
Journal:  Nat Photonics       Date:  2007       Impact factor: 38.771

3.  CT-based handling and analysis of preclinical multimodality imaging data of bone metastases.

Authors:  Thomas J A Snoeks; Martin Baiker; Eric L Kaijzel; Boudewijn P F Lelieveldt; Clemens W G M Löwik
Journal:  Bonekey Rep       Date:  2012-05-09

4.  Polyphenol-rich sweet potato greens extract inhibits proliferation and induces apoptosis in prostate cancer cells in vitro and in vivo.

Authors:  Prasanthi Karna; Sushma R Gundala; Meenakshi V Gupta; Shahab A Shamsi; Ralphenia D Pace; Clayton Yates; Satya Narayan; Ritu Aneja
Journal:  Carcinogenesis       Date:  2011-09-26       Impact factor: 4.944

Review 5.  Drug discovery in prostate cancer mouse models.

Authors:  Kenneth C Valkenburg; Kenneth J Pienta
Journal:  Expert Opin Drug Discov       Date:  2015-06-01       Impact factor: 6.098

6.  Synergistic antimicrotubule therapy for prostate cancer.

Authors:  Vaishali Pannu; Prasanthi Karna; Hari Krishna Sajja; Deep Shukla; Ritu Aneja
Journal:  Biochem Pharmacol       Date:  2010-11-16       Impact factor: 5.858

7.  A novel microtubule-modulating agent induces mitochondrially driven caspase-dependent apoptosis via mitotic checkpoint activation in human prostate cancer cells.

Authors:  Ritu Aneja; Tohru Miyagi; Prasanthi Karna; Tucker Ezell; Deep Shukla; Meenakshi Vij Gupta; Clayton Yates; Sreenivasa R Chinni; Haiyen Zhau; Leland W K Chung; Harish C Joshi
Journal:  Eur J Cancer       Date:  2010-03-18       Impact factor: 9.162

Review 8.  Genetically engineered mouse models of prostate cancer.

Authors:  Maxime Parisotto; Daniel Metzger
Journal:  Mol Oncol       Date:  2013-02-14       Impact factor: 6.603

9.  Alternatives to animal experimentation for hormonal compounds research.

Authors:  M Penza; M Jeremic; C Montani; M Unkila; L Caimi; G Mazzoleni; Diego Di Lorenzo
Journal:  Genes Nutr       Date:  2009-05-26       Impact factor: 5.523

10.  Visualizing the prostate gland by MR imaging in young and old mice.

Authors:  Murali Ravoori; Jyoti Duggal; Mihai Gagea; Lin Han; Sheela Singh; Ping Liu; Wei Wei; Dustin K Ragan; James A Bankson; Jingfei Ma; Vikas Kundra
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.